#category	term ID	term description	observed gene count	background gene count	strength	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
GO Process	GO:0031297	Replication fork processing	5	45	2.44	7.47e-08	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0071479	Cellular response to ionizing radiation	4	75	2.12	5.19e-05	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,BRCA2,BRCA1
GO Process	GO:0034502	Protein localization to chromosome	4	92	2.03	9.53e-05	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497	RB1,ATR,ATRX,BRCA2
GO Process	GO:0070198	Protein localization to chromosome, telomeric region	3	17	2.64	0.00011	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497	ATR,ATRX,BRCA2
GO Process	GO:0010564	Regulation of cell cycle process	6	716	1.31	0.00012	9606.ENSP00000267163,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0033365	Protein localization to organelle	6	713	1.32	0.00012	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497	RB1,WRN,MCPH1,ATR,ATRX,BRCA2
GO Process	GO:0022402	Cell cycle process	6	835	1.25	0.00024	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,MCPH1,ATRX,BRCA2,BRCA1
GO Process	GO:0042770	Signal transduction in response to DNA damage	4	135	1.86	0.00024	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0051276	Chromosome organization	6	968	1.18	0.00045	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0006281	DNA repair	5	497	1.39	0.00060	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0051052	Regulation of DNA metabolic process	5	541	1.36	0.00080	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0010332	Response to gamma radiation	3	55	2.13	0.0012	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497	WRN,ATR,BRCA2
GO Process	GO:0031324	Negative regulation of cellular metabolic process	7	2265	0.88	0.0015	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0033044	Regulation of chromosome organization	4	253	1.59	0.0015	9606.ENSP00000267163,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441	RB1,MCPH1,ATR,ATRX
GO Process	GO:0010948	Negative regulation of cell cycle process	4	272	1.56	0.0018	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000418960	RB1,ATR,ATRX,BRCA1
GO Process	GO:0051172	Negative regulation of nitrogen compound metabolic process	7	2403	0.86	0.0020	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0051054	Positive regulation of DNA metabolic process	4	304	1.51	0.0025	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA1
GO Process	GO:0007420	Brain development	5	775	1.2	0.0029	9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497	NTRK2,WRN,MCPH1,ATRX,BRCA2
GO Process	GO:0045934	Negative regulation of nucleobase-containing compound metabolic process	6	1562	0.98	0.0032	9606.ENSP00000267163,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0000723	Telomere maintenance	3	97	1.88	0.0034	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497	WRN,ATR,BRCA2
GO Process	GO:0010605	Negative regulation of macromolecule metabolic process	7	2760	0.8	0.0036	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0000724	Double-strand break repair via homologous recombination	3	114	1.81	0.0050	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
GO Process	GO:1901987	Regulation of cell cycle phase transition	4	431	1.36	0.0063	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATR,BRCA2,BRCA1
GO Process	GO:0031325	Positive regulation of cellular metabolic process	7	3114	0.74	0.0067	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0006275	Regulation of DNA replication	3	136	1.73	0.0070	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497	ATR,ATRX,BRCA2
GO Process	GO:0010225	Response to UV-C	2	15	2.52	0.0070	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
GO Process	GO:0051173	Positive regulation of nitrogen compound metabolic process	7	3166	0.74	0.0070	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0090399	Replicative senescence	2	16	2.49	0.0074	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
GO Process	GO:0009411	Response to UV	3	150	1.69	0.0080	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497	WRN,ATR,BRCA2
GO Process	GO:0045935	Positive regulation of nucleobase-containing compound metabolic process	6	2056	0.86	0.0095	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0000226	Microtubule cytoskeleton organization	4	542	1.26	0.0110	9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	MCPH1,ATRX,BRCA2,BRCA1
GO Process	GO:0006996	Organelle organization	7	3470	0.7	0.0110	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0007063	Regulation of sister chromatid cohesion	2	21	2.37	0.0110	9606.ENSP00000267163,9606.ENSP00000362441	RB1,ATRX
GO Process	GO:1903047	Mitotic cell cycle process	4	537	1.26	0.0110	9606.ENSP00000267163,9606.ENSP00000342924,9606.ENSP00000369497,9606.ENSP00000418960	RB1,MCPH1,BRCA2,BRCA1
GO Process	GO:0033043	Regulation of organelle organization	5	1190	1.01	0.0111	9606.ENSP00000267163,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000418960	RB1,MCPH1,ATR,ATRX,BRCA1
GO Process	GO:0010604	Positive regulation of macromolecule metabolic process	7	3533	0.69	0.0113	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0007399	Nervous system development	6	2188	0.83	0.0118	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497	RB1,NTRK2,WRN,MCPH1,ATRX,BRCA2
GO Process	GO:0035518	Histone H2A monoubiquitination	2	23	2.33	0.0118	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
GO Process	GO:0090304	Nucleic acid metabolic process	6	2203	0.83	0.0120	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0033260	Nuclear DNA replication	2	24	2.31	0.0122	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
GO Process	GO:0031323	Regulation of cellular metabolic process	8	5681	0.54	0.0124	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0051171	Regulation of nitrogen compound metabolic process	8	5734	0.54	0.0129	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0051570	Regulation of histone H3-K9 methylation	2	27	2.26	0.0143	9606.ENSP00000362441,9606.ENSP00000418960	ATRX,BRCA1
GO Process	GO:2000001	Regulation of DNA damage checkpoint	2	27	2.26	0.0143	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
GO Process	GO:0080090	Regulation of primary metabolic process	8	5899	0.52	0.0150	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0051128	Regulation of cellular component organization	6	2365	0.8	0.0151	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000418960	RB1,NTRK2,MCPH1,ATR,ATRX,BRCA1
GO Process	GO:0071480	Cellular response to gamma radiation	2	29	2.23	0.0151	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
GO Process	GO:1901699	Cellular response to nitrogen compound	4	637	1.19	0.0151	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000418960	RB1,NTRK2,ATRX,BRCA1
GO Process	GO:0080134	Regulation of response to stress	5	1373	0.95	0.0163	9606.ENSP00000267163,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	RB1,MCPH1,ATR,BRCA2,BRCA1
GO Process	GO:0008156	Negative regulation of DNA replication	2	32	2.19	0.0166	9606.ENSP00000343741,9606.ENSP00000369497	ATR,BRCA2
GO Process	GO:1901988	Negative regulation of cell cycle phase transition	3	225	1.52	0.0167	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000418960	RB1,ATR,BRCA1
GO Process	GO:0060255	Regulation of macromolecule metabolic process	8	6249	0.5	0.0202	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0019219	Regulation of nucleobase-containing compound metabolic process	7	4074	0.63	0.0206	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0035556	Intracellular signal transduction	5	1518	0.91	0.0241	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATR,ATRX,BRCA2,BRCA1
GO Process	GO:0007275	Multicellular organism development	7	4209	0.61	0.0251	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATRX,BRCA2,BRCA1
GO Process	GO:0030330	DNA damage response, signal transduction by p53 class mediator	2	44	2.05	0.0273	9606.ENSP00000362441,9606.ENSP00000369497	ATRX,BRCA2
GO Process	GO:0051179	Localization	7	4512	0.58	0.0362	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497	RB1,NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2
GO Process	GO:2001020	Regulation of response to DNA damage stimulus	3	316	1.37	0.0366	9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	ATR,BRCA2,BRCA1
GO Process	GO:0046605	Regulation of centrosome cycle	2	56	1.94	0.0384	9606.ENSP00000342924,9606.ENSP00000418960	MCPH1,BRCA1
GO Process	GO:0090329	Regulation of DNA-templated DNA replication	2	57	1.94	0.0390	9606.ENSP00000362441,9606.ENSP00000369497	ATRX,BRCA2
GO Process	GO:0090398	Cellular senescence	2	60	1.91	0.0427	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
GO Process	GO:0045787	Positive regulation of cell cycle	3	349	1.33	0.0462	9606.ENSP00000267163,9606.ENSP00000362441,9606.ENSP00000369497	RB1,ATRX,BRCA2
GO Function	GO:0032405	MutLalpha complex binding	2	4	3.09	0.0107	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
GO Component	GO:0000781	Chromosome, telomeric region	3	143	1.71	0.0142	9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000369497	WRN,ATRX,BRCA2
GO Component	GO:0000800	Lateral element	2	14	2.55	0.0142	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
GO Component	GO:0005694	Chromosome	6	1850	0.9	0.0142	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
GO Component	GO:0016604	Nuclear body	5	833	1.17	0.0142	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA1
GO Component	GO:0016605	PML body	3	103	1.86	0.0142	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441	RB1,ATR,ATRX
GO Component	GO:0015630	Microtubule cytoskeleton	5	1355	0.96	0.0249	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,MCPH1,BRCA2,BRCA1
GO Component	GO:0000228	Nuclear chromosome	3	244	1.48	0.0304	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
GO Component	GO:0000152	Nuclear ubiquitin ligase complex	2	46	2.03	0.0315	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
GO Component	GO:0000793	Condensed chromosome	3	275	1.43	0.0315	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
GO Component	GO:0005654	Nucleoplasm	7	4169	0.62	0.0315	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
GO Component	GO:0005815	Microtubule organizing center	4	825	1.08	0.0315	9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000369497,9606.ENSP00000418960	WRN,MCPH1,BRCA2,BRCA1
GO Component	GO:1990391	DNA repair complex	2	43	2.06	0.0315	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
STRING clusters	CL:6149	Homologous DNA Pairing and Strand Exchange, and Response to intra-S DNA damage checkpoint signaling	4	48	2.31	1.37e-05	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,BRCA2,BRCA1
STRING clusters	CL:6150	Resolution of D-loop Structures through Holliday Junction Intermediates, and RIDDLE syndrome	3	35	2.32	0.00021	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
STRING clusters	CL:6151	Resolution of D-loop Structures through Holliday Junction Intermediates, and DNA translocase activity	2	22	2.35	0.0201	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
KEGG	hsa03460	Fanconi anemia pathway	3	51	2.16	0.00036	9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	ATR,BRCA2,BRCA1
KEGG	hsa05224	Breast cancer	3	146	1.7	0.0039	9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000418960	RB1,BRCA2,BRCA1
KEGG	hsa03440	Homologous recombination	2	38	2.11	0.0125	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
KEGG	hsa05212	Pancreatic cancer	2	71	1.84	0.0314	9606.ENSP00000267163,9606.ENSP00000369497	RB1,BRCA2
Reactome	HSA-1640170	Cell Cycle	7	658	1.42	8.57e-07	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Reactome	HSA-9709570	Impaired BRCA2 binding to RAD51	4	34	2.46	9.34e-07	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,BRCA2,BRCA1
Reactome	HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	4	39	2.4	1.04e-06	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,BRCA2,BRCA1
Reactome	HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	3	26	2.45	2.65e-05	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Reactome	HSA-9701192	Defective homologous recombination repair (HRR) due to BRCA1 loss of function	3	24	2.49	2.65e-05	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Reactome	HSA-9704331	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function	3	24	2.49	2.65e-05	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Reactome	HSA-9704646	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function	3	24	2.49	2.65e-05	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Reactome	HSA-9709603	Impaired BRCA2 binding to PALB2	3	24	2.49	2.65e-05	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Reactome	HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	3	32	2.36	3.62e-05	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Reactome	HSA-5685938	HDR through Single Strand Annealing (SSA)	3	37	2.3	4.92e-05	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000418960	WRN,ATR,BRCA1
Reactome	HSA-69473	G2/M DNA damage checkpoint	3	77	1.98	0.00039	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000418960	WRN,ATR,BRCA1
Reactome	HSA-5693607	Processing of DNA double-strand break ends	3	80	1.97	0.00041	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000418960	WRN,ATR,BRCA1
Reactome	HSA-1500620	Meiosis	3	88	1.92	0.00050	9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	ATR,BRCA2,BRCA1
Reactome	HSA-6804756	Regulation of TP53 Activity through Phosphorylation	3	92	1.9	0.00055	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000418960	WRN,ATR,BRCA1
Reactome	HSA-1643685	Disease	6	1702	0.94	0.00089	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
Reactome	HSA-9675126	Diseases of mitotic cell cycle	2	38	2.11	0.0085	9606.ENSP00000267163,9606.ENSP00000362441	RB1,ATRX
Reactome	HSA-2299718	Condensation of Prophase Chromosomes	2	43	2.06	0.0104	9606.ENSP00000267163,9606.ENSP00000342924	RB1,MCPH1
Reactome	HSA-912446	Meiotic recombination	2	56	1.94	0.0163	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Reactome	HSA-1221632	Meiotic synapsis	2	60	1.91	0.0181	9606.ENSP00000343741,9606.ENSP00000418960	ATR,BRCA1
Reactome	HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	2	62	1.9	0.0187	9606.ENSP00000343741,9606.ENSP00000418960	ATR,BRCA1
Reactome	HSA-3108214	SUMOylation of DNA damage response and repair proteins	2	75	1.82	0.0256	9606.ENSP00000298139,9606.ENSP00000418960	WRN,BRCA1
Reactome	HSA-157579	Telomere Maintenance	2	93	1.72	0.0380	9606.ENSP00000298139,9606.ENSP00000362441	WRN,ATRX
Reactome	HSA-212436	Generic Transcription Pathway	4	1215	0.91	0.0488	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000418960	RB1,WRN,ATR,BRCA1
WikiPathways	WP4016	DNA IR-damage and cellular response via ATR	5	81	2.18	6.09e-08	9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	WRN,MCPH1,ATR,BRCA2,BRCA1
WikiPathways	WP3959	DNA IR-double strand breaks and cellular response via ATM	4	55	2.25	1.96e-06	9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	MCPH1,ATR,BRCA2,BRCA1
WikiPathways	WP4946	DNA repair pathways, full network	4	120	1.91	2.67e-05	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,BRCA2,BRCA1
WikiPathways	WP4262	Breast cancer pathway	4	154	1.81	5.30e-05	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATR,BRCA2,BRCA1
WikiPathways	WP1971	Integrated cancer pathway	3	44	2.23	0.00011	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000418960	RB1,ATR,BRCA1
WikiPathways	WP1530	miRNA regulation of DNA damage response	3	71	2.02	0.00034	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000418960	RB1,ATR,BRCA1
WikiPathways	WP707	DNA damage response	3	69	2.03	0.00034	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000418960	RB1,ATR,BRCA1
WikiPathways	WP2261	Glioblastoma signaling pathways	3	82	1.95	0.00042	9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000418960	RB1,BRCA2,BRCA1
WikiPathways	WP2263	Androgen receptor network in prostate cancer	3	109	1.83	0.00085	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000418960	RB1,ATR,BRCA1
WikiPathways	WP5316	Primary ovarian insufficiency	3	171	1.64	0.0029	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
WikiPathways	WP3651	Pathways affected in adenoid cystic carcinoma	2	65	1.88	0.0223	9606.ENSP00000362441,9606.ENSP00000418960	ATRX,BRCA1
WikiPathways	WP4263	Pancreatic adenocarcinoma pathway	2	86	1.76	0.0353	9606.ENSP00000267163,9606.ENSP00000369497	RB1,BRCA2
WikiPathways	WP138	Androgen receptor signaling pathway	2	90	1.74	0.0356	9606.ENSP00000267163,9606.ENSP00000418960	RB1,BRCA1
Monarch	HP:0000002	Abnormality of body height	7	1253	1.14	5.72e-05	9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0000163	Abnormal oral cavity morphology	8	1901	1.02	5.72e-05	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0001507	Growth abnormality	8	2182	0.96	5.72e-05	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0003002	Breast carcinoma	4	54	2.26	5.72e-05	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,BRCA2,BRCA1
Monarch	HP:0004322	Short stature	7	1152	1.17	5.72e-05	9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0004325	Decreased body weight	7	1274	1.13	5.72e-05	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0012443	Abnormality of brain morphology	8	2254	0.94	5.72e-05	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0040069	Abnormal lower limb bone morphology	6	648	1.36	5.72e-05	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0200006	Slanting of the palpebral fissure	6	599	1.39	5.72e-05	9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0011793	Neoplasm by anatomical site	6	732	1.3	5.77e-05	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0012639	Abnormal nervous system morphology	8	2546	0.89	6.01e-05	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0000324	Facial asymmetry	4	116	1.93	6.15e-05	9606.ENSP00000277120,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,ATR,BRCA2,BRCA1
Monarch	HP:0011842	Abnormal skeletal morphology	8	2573	0.88	6.15e-05	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0010468	Aplasia/Hypoplasia of the testes	4	146	1.83	0.00010	9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATRX,BRCA2,BRCA1
Monarch	HP:0001367	Abnormal joint morphology	6	905	1.21	0.00011	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0000290	Abnormality of the forehead	6	926	1.2	0.00012	9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0000340	Sloping forehead	4	161	1.79	0.00014	9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	MCPH1,ATR,BRCA2,BRCA1
Monarch	HP:0001999	Abnormal facial shape	6	978	1.18	0.00015	9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0033127	Abnormality of the musculoskeletal system	8	3173	0.79	0.00017	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0007379	Neoplasm of the genitourinary tract	4	179	1.74	0.00018	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,BRCA2,BRCA1
Monarch	HP:0000252	Microcephaly	6	1080	1.14	0.00025	9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0040195	Decreased head circumference	6	1088	1.13	0.00025	9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0040064	Abnormality of limbs	7	2018	0.93	0.00029	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0001824	Weight loss	4	218	1.65	0.00033	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATR,BRCA2,BRCA1
Monarch	HP:0012372	Abnormal eye morphology	7	2077	0.92	0.00033	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0100615	Ovarian neoplasm	3	52	2.15	0.00034	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Monarch	HP:0004377	Hematological neoplasm	4	232	1.63	0.00039	9606.ENSP00000267163,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATRX,BRCA2,BRCA1
Monarch	HP:0000119	Abnormality of the genitourinary system	7	2189	0.9	0.00042	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0009121	Abnormal axial skeleton morphology	7	2206	0.89	0.00043	9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0002861	Melanoma	3	61	2.08	0.00047	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Monarch	HP:0000069	Abnormality of the ureter	4	257	1.58	0.00048	9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	MCPH1,ATRX,BRCA2,BRCA1
Monarch	HP:0001347	Hyperreflexia	5	645	1.28	0.00048	9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,MCPH1,ATRX,BRCA2,BRCA1
Monarch	HP:0002823	Abnormality of femur morphology	4	253	1.59	0.00048	9606.ENSP00000267163,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATRX,BRCA2,BRCA1
Monarch	HP:0003330	Abnormal bone structure	5	639	1.28	0.00048	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,MCPH1,BRCA2,BRCA1
Monarch	HP:0000582	Upslanted palpebral fissure	4	259	1.58	0.00049	9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	MCPH1,ATRX,BRCA2,BRCA1
Monarch	HP:0007364	Aplasia/Hypoplasia of the cerebrum	6	1300	1.06	0.00049	9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0010936	Abnormality of the lower urinary tract	5	652	1.28	0.00049	9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0008678	Renal hypoplasia/aplasia	4	264	1.57	0.00050	9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	MCPH1,ATRX,BRCA2,BRCA1
Monarch	HP:0011314	Abnormal long bone morphology	5	675	1.26	0.00052	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0011792	Neoplasm by histology	4	275	1.55	0.00054	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,BRCA2,BRCA1
Monarch	HP:0009821	Forearm undergrowth	3	71	2.02	0.00057	9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	ATR,BRCA2,BRCA1
Monarch	HP:0000047	Hypospadias	4	290	1.53	0.00065	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0004209	Clinodactyly of the 5th finger	4	292	1.53	0.00066	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0009179	Deviation of the 5th finger	4	293	1.53	0.00066	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0030406	Primary peritoneal carcinoma	2	6	2.91	0.00072	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0001763	Pes planus	4	308	1.5	0.00073	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0006501	Aplasia/Hypoplasia of the radius	3	81	1.96	0.00073	9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	ATR,BRCA2,BRCA1
Monarch	HP:0000035	Abnormal testis morphology	5	793	1.19	0.00088	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0001263	Global developmental delay	6	1559	0.98	0.00093	9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0000135	Hypogonadism	4	343	1.46	0.00094	9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATRX,BRCA2,BRCA1
Monarch	HP:0002863	Myelodysplasia	3	98	1.88	0.0010	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0000010	Recurrent urinary tract infections	3	99	1.87	0.0011	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0000079	Abnormality of the urinary system	6	1657	0.95	0.0012	9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0001249	Intellectual disability	6	1656	0.95	0.0012	9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,MCPH1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0005922	Abnormal hand morphology	5	870	1.15	0.0012	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0011121	Abnormality of skin morphology	6	1648	0.95	0.0012	9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0010786	Urinary tract neoplasm	3	110	1.83	0.0013	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000369497	RB1,WRN,BRCA2
Monarch	HP:0002251	Aganglionic megacolon	3	113	1.82	0.0014	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0004362	Abnormality of enteric ganglion morphology	3	113	1.82	0.0014	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0001508	Failure to thrive	5	949	1.11	0.0016	9606.ENSP00000277120,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0010460	Abnormality of the female genitalia	4	422	1.37	0.0017	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,BRCA2,BRCA1
Monarch	HP:0009115	Aplasia/hypoplasia involving the skeleton	5	985	1.1	0.0018	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0000174	Abnormal palate morphology	5	1035	1.08	0.0022	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0001909	Leukemia	3	141	1.72	0.0023	9606.ENSP00000267163,9606.ENSP00000362441,9606.ENSP00000369497	RB1,ATRX,BRCA2
Monarch	HP:0012252	Abnormal respiratory system morphology	5	1067	1.06	0.0024	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATRX,BRCA2,BRCA1
Monarch	HP:0000077	Abnormality of the kidney	5	1077	1.06	0.0025	9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,MCPH1,ATRX,BRCA2,BRCA1
Monarch	HP:0010935	Abnormality of the upper urinary tract	5	1101	1.05	0.0027	9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,MCPH1,ATRX,BRCA2,BRCA1
Monarch	HP:0011027	Abnormal fallopian tube morphology	2	18	2.44	0.0028	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0012125	Prostate cancer	2	18	2.44	0.0028	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0000268	Dolichocephaly	3	158	1.67	0.0029	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0006496	Aplasia/hypoplasia involving bones of the upper limbs	4	511	1.28	0.0029	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,BRCA2,BRCA1
Monarch	HP:0010972	Anemia of inadequate production	3	160	1.66	0.0029	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0001881	Abnormal leukocyte morphology	4	517	1.28	0.0030	9606.ENSP00000267163,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATRX,BRCA2,BRCA1
Monarch	HP:0010987	Abnormal cellular immune system morphology	4	517	1.28	0.0030	9606.ENSP00000267163,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATRX,BRCA2,BRCA1
Monarch	HP:0001939	Abnormality of metabolism/homeostasis	6	2168	0.83	0.0037	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,MCPH1,ATRX,BRCA2,BRCA1
Monarch	HP:0100491	Abnormality of lower limb joint	4	558	1.25	0.0038	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0001871	Abnormality of blood and blood-forming tissues	5	1214	1.01	0.0039	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0005522	Pyridoxine-responsive sideroblastic anemia	2	23	2.33	0.0039	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0001760	Abnormal foot morphology	5	1253	0.99	0.0043	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0010293	Aplasia/Hypoplasia of the uvula	2	25	2.29	0.0043	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0010469	Absent testis	2	25	2.29	0.0043	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0011119	Abnormal nasal dorsum morphology	3	191	1.59	0.0043	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441	WRN,ATR,ATRX
Monarch	HP:0003549	Abnormality of connective tissue	5	1294	0.98	0.0048	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0000028	Cryptorchidism	4	619	1.2	0.0049	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0000175	Cleft palate	4	617	1.2	0.0049	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATR,BRCA2,BRCA1
Monarch	HP:0100867	Duodenal stenosis	2	29	2.23	0.0052	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0000218	High palate	4	635	1.19	0.0053	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0000508	Ptosis	4	647	1.18	0.0055	9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,ATRX,BRCA2,BRCA1
Monarch	HP:0002669	Osteosarcoma	2	30	2.22	0.0055	9606.ENSP00000267163,9606.ENSP00000298139	RB1,WRN
Monarch	HP:0002827	Hip dislocation	3	215	1.54	0.0055	9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	ATR,BRCA2,BRCA1
Monarch	HP:0012373	Abnormal eye physiology	6	2405	0.79	0.0055	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0040012	Chromosome breakage	2	30	2.22	0.0055	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0100587	Abnormal preputium morphology	2	30	2.22	0.0055	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0100760	Clubbing of toes	2	30	2.22	0.0055	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0007378	Neoplasm of the gastrointestinal tract	3	221	1.52	0.0057	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Monarch	HP:0000347	Micrognathia	4	659	1.17	0.0058	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0001626	Abnormality of the cardiovascular system	6	2438	0.78	0.0058	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0009118	Aplasia/Hypoplasia of the mandible	4	660	1.17	0.0058	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0011024	Abnormality of the gastrointestinal tract	5	1384	0.95	0.0058	9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,WRN,ATRX,BRCA2,BRCA1
Monarch	HP:0001537	Umbilical hernia	3	228	1.51	0.0059	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0002981	Abnormality of the calf	3	229	1.51	0.0060	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441	RB1,ATR,ATRX
Monarch	HP:0001551	Abnormal umbilicus morphology	3	235	1.5	0.0063	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0007874	Almond-shaped palpebral fissure	2	35	2.15	0.0064	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0000144	Decreased fertility	3	245	1.48	0.0070	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Monarch	HP:0000366	Abnormality of the nose	5	1470	0.92	0.0071	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0000496	Abnormality of eye movement	5	1491	0.92	0.0075	9606.ENSP00000277120,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0200007	Abnormal size of the palpebral fissures	3	267	1.44	0.0086	9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	ATR,BRCA2,BRCA1
Monarch	HP:0100887	Abnormality of globe size	3	268	1.44	0.0087	9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	ATR,BRCA2,BRCA1
Monarch	HP:0002683	Abnormal calvaria morphology	4	762	1.11	0.0088	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0100526	Neoplasm of the lung	2	43	2.06	0.0089	9606.ENSP00000267163,9606.ENSP00000298139	RB1,WRN
Monarch	HP:0002997	Obsolete Abnormality of the ulna	2	46	2.03	0.0101	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0000692	Tooth malposition	3	286	1.41	0.0103	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000418960	ATR,ATRX,BRCA1
Monarch	HP:0000164	Abnormality of the dentition	4	821	1.08	0.0112	9606.ENSP00000277120,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000418960	NTRK2,ATR,ATRX,BRCA1
Monarch	HP:0000813	Bicornuate uterus	2	49	2.0	0.0112	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0010938	Abnormal external nose morphology	4	816	1.08	0.0112	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA1
Monarch	HP:0008070	Sparse hair	3	300	1.39	0.0114	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000418960	WRN,ATR,BRCA1
Monarch	HP:0100037	Abnormality of the scalp hair	3	302	1.39	0.0116	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000418960	WRN,ATR,BRCA1
Monarch	HP:0001873	Thrombocytopenia	3	305	1.38	0.0118	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0002597	Abnormality of the vasculature	5	1673	0.87	0.0118	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0002894	Neoplasm of the pancreas	2	52	1.98	0.0118	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0003022	Hypoplasia of the ulna	2	54	1.96	0.0125	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0100026	Arteriovenous malformation	2	54	1.96	0.0125	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0002245	Meckel diverticulum	2	56	1.94	0.0133	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0011873	Abnormal platelet count	3	323	1.36	0.0133	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0005344	Abnormal carotid artery morphology	2	57	1.94	0.0137	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0000444	Convex nasal ridge	2	60	1.91	0.0148	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
Monarch	HP:0000486	Strabismus	4	903	1.04	0.0148	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0002650	Scoliosis	4	908	1.04	0.0148	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0007565	Multiple cafe-au-lait spots	2	60	1.91	0.0148	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0002898	Embryonal neoplasm	2	61	1.91	0.0149	9606.ENSP00000267163,9606.ENSP00000369497	RB1,BRCA2
Monarch	HP:0000525	Abnormality iris morphology	3	352	1.32	0.0160	9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000418960	RB1,BRCA2,BRCA1
Monarch	HP:0001199	Triphalangeal thumb	2	64	1.89	0.0161	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0001376	Limitation of joint mobility	3	356	1.32	0.0163	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441	WRN,ATR,ATRX
Monarch	HP:0002575	Tracheoesophageal fistula	2	65	1.88	0.0163	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0011893	Abnormal leukocyte count	3	367	1.3	0.0176	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0000072	Hydroureter	2	69	1.85	0.0181	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0011339	Abnormality of upper lip vermillion	3	373	1.3	0.0181	9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000418960	MCPH1,ATRX,BRCA1
Monarch	HP:0010866	Abdominal wall defect	3	375	1.29	0.0183	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0000505	Visual impairment	4	995	1.0	0.0193	9606.ENSP00000277120,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,ATRX,BRCA2,BRCA1
Monarch	HP:0010993	Abnormal cerebral subcortex morphology	4	999	0.99	0.0196	9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441	NTRK2,MCPH1,ATR,ATRX
Monarch	HP:0010864	Intellectual disability, severe	3	390	1.28	0.0201	9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000362441	NTRK2,MCPH1,ATRX
Monarch	HP:0000812	Abnormal internal genitalia	3	391	1.28	0.0202	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Monarch	HP:0000377	Abnormal pinna morphology	4	1019	0.99	0.0208	9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATR,ATRX,BRCA2,BRCA1
Monarch	HP:0011004	Abnormal systemic arterial morphology	3	398	1.27	0.0211	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Monarch	HP:0004349	Reduced bone mineral density	3	413	1.25	0.0232	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Monarch	HP:0000752	Hyperactivity	3	423	1.24	0.0244	9606.ENSP00000277120,9606.ENSP00000343741,9606.ENSP00000362441	NTRK2,ATR,ATRX
Monarch	HP:0008572	External ear malformation	2	86	1.76	0.0255	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0011276	Vascular skin abnormality	3	433	1.23	0.0259	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441	WRN,ATR,ATRX
Monarch	HP:0004328	Abnormal anterior eye segment morphology	4	1106	0.95	0.0271	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,BRCA2,BRCA1
Monarch	HP:0001882	Leukopenia	2	90	1.74	0.0273	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0000286	Epicanthus	3	447	1.22	0.0279	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0000027	Azoospermia	2	93	1.72	0.0289	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0002414	Spina bifida	2	94	1.72	0.0294	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0001098	Abnormal fundus morphology	4	1143	0.94	0.0300	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000362441	RB1,NTRK2,WRN,ATRX
Monarch	HP:0008053	Aplasia/Hypoplasia of the iris	2	96	1.71	0.0302	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0001511	Intrauterine growth retardation	3	469	1.2	0.0310	9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	ATR,BRCA2,BRCA1
Monarch	HP:0009726	Renal neoplasm	2	98	1.7	0.0310	9606.ENSP00000298139,9606.ENSP00000369497	WRN,BRCA2
Monarch	HP:0002488	Acute leukemia	2	99	1.7	0.0313	9606.ENSP00000362441,9606.ENSP00000369497	ATRX,BRCA2
Monarch	HP:0011017	Abnormal cellular physiology	3	473	1.19	0.0313	9606.ENSP00000342924,9606.ENSP00000369497,9606.ENSP00000418960	MCPH1,BRCA2,BRCA1
Monarch	HP:0002209	Sparse scalp hair	2	100	1.69	0.0317	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
Monarch	HP:0000453	Choanal atresia	2	101	1.69	0.0322	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0005927	Aplasia/hypoplasia involving bones of the hand	3	480	1.19	0.0323	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Monarch	HP:0001053	Hypopigmented skin patches	2	102	1.68	0.0326	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0000689	Dental malocclusion	2	104	1.68	0.0338	9606.ENSP00000343741,9606.ENSP00000418960	ATR,BRCA1
Monarch	HP:0000275	Narrow face	2	105	1.67	0.0340	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
Monarch	HP:0001903	Anemia	3	498	1.17	0.0352	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0002509	Limb hypertonia	2	112	1.64	0.0378	9606.ENSP00000277120,9606.ENSP00000362441	NTRK2,ATRX
Monarch	HP:0002023	Anal atresia	2	113	1.64	0.0381	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0001009	Telangiectasia	2	114	1.64	0.0385	9606.ENSP00000298139,9606.ENSP00000343741	WRN,ATR
Monarch	HP:0001646	Abnormal aortic valve morphology	2	116	1.63	0.0394	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0000076	Vesicoureteral reflux	2	125	1.6	0.0451	9606.ENSP00000342924,9606.ENSP00000362441	MCPH1,ATRX
Monarch	HP:0001671	Abnormal cardiac septum morphology	3	556	1.12	0.0455	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
Monarch	HP:0011849	Abnormal bone ossification	3	558	1.12	0.0457	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Monarch	HP:0012745	Short palpebral fissure	2	127	1.59	0.0458	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0001636	Tetralogy of Fallot	2	128	1.59	0.0462	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0011843	Abnormal musculoskeletal physiology	4	1330	0.87	0.0462	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441	RB1,WRN,ATR,ATRX
Monarch	HP:0100006	Neoplasm of the central nervous system	2	128	1.59	0.0462	9606.ENSP00000267163,9606.ENSP00000298139	RB1,WRN
Monarch	HP:0025633	Abnormal ureter morphology	2	129	1.58	0.0466	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0030962	Abnormal morphology of the great vessels	3	571	1.11	0.0478	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
Monarch	HP:0000717	Autism	2	132	1.57	0.0483	9606.ENSP00000277120,9606.ENSP00000362441	NTRK2,ATRX
Monarch	HP:0002778	Abnormal tracheal morphology	2	132	1.57	0.0483	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
Monarch	HP:0012041	Decreased fertility in males	2	133	1.57	0.0487	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:0050686	Organ system cancer	6	757	1.29	0.00040	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,ATRX,BRCA2,BRCA1
DISEASES	DOID:10283	Prostate cancer	3	52	2.15	0.00090	9606.ENSP00000298139,9606.ENSP00000369497,9606.ENSP00000418960	WRN,BRCA2,BRCA1
DISEASES	DOID:1791	Peritoneal carcinoma	2	3	3.22	0.00090	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:4947	Cholangiocarcinoma	3	40	2.27	0.00090	9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000418960	RB1,BRCA2,BRCA1
DISEASES	DOID:8029	Sporadic breast cancer	2	4	3.09	0.00090	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:0050671	Female breast cancer	2	6	2.91	0.00099	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:1614	Male breast cancer	2	5	2.99	0.00099	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:1963	Fallopian tube carcinoma	2	6	2.91	0.00099	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:3012	Li-Fraumeni syndrome	2	6	2.91	0.00099	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:3114	Serous cystadenocarcinoma	2	5	2.99	0.00099	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:5683	Hereditary breast ovarian cancer syndrome	2	7	2.85	0.00099	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:6741	Bilateral breast cancer	2	5	2.99	0.00099	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:8791	Breast carcinoma in situ	2	5	2.99	0.00099	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:0050687	Cell type cancer	4	451	1.34	0.0025	9606.ENSP00000267163,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATRX,BRCA2,BRCA1
DISEASES	DOID:3883	Lynch syndrome	2	15	2.52	0.0026	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:4001	Ovarian carcinoma	2	16	2.49	0.0028	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:2355	Anemia	3	156	1.68	0.0033	9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	ATRX,BRCA2,BRCA1
DISEASES	DOID:13636	Fanconi anemia	2	25	2.29	0.0053	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
DISEASES	DOID:0080015	Physical disorder	4	722	1.13	0.0113	9606.ENSP00000277120,9606.ENSP00000342924,9606.ENSP00000369497,9606.ENSP00000418960	NTRK2,MCPH1,BRCA2,BRCA1
DISEASES	DOID:1324	Lung cancer	2	64	1.89	0.0270	9606.ENSP00000267163,9606.ENSP00000369497	RB1,BRCA2
DISEASES	DOID:7	Disease of anatomical entity	7	4798	0.56	0.0279	9606.ENSP00000267163,9606.ENSP00000277120,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,NTRK2,WRN,MCPH1,ATRX,BRCA2,BRCA1
DISEASES	DOID:201	Connective tissue cancer	2	82	1.78	0.0399	9606.ENSP00000277120,9606.ENSP00000362441	NTRK2,ATRX
TISSUES	BTO:0001271	Leukemia cell	6	1067	1.14	0.0016	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
TISSUES	BTO:0001541	Pronephros	4	219	1.65	0.0016	9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATRX,BRCA2,BRCA1
TISSUES	BTO:0000180	Cervical carcinoma cell	4	322	1.49	0.0030	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATR,BRCA2,BRCA1
TISSUES	BTO:0000744	Lymphocytic leukemia cell	4	419	1.37	0.0066	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000418960	RB1,WRN,ATRX,BRCA1
TISSUES	BTO:0000583	Bone marrow cancer cell	4	442	1.35	0.0068	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000369497,9606.ENSP00000418960	RB1,ATR,BRCA2,BRCA1
COMPARTMENTS	GOCC:0016604	Nuclear body	5	381	1.51	0.00034	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA1
COMPARTMENTS	GOCC:0005694	Chromosome	6	951	1.19	0.00038	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
COMPARTMENTS	GOCC:0005654	Nucleoplasm	6	1146	1.11	0.00076	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
COMPARTMENTS	GOCC:0000781	Chromosome, telomeric region	3	71	2.02	0.0016	9606.ENSP00000298139,9606.ENSP00000362441,9606.ENSP00000369497	WRN,ATRX,BRCA2
COMPARTMENTS	GOCC:0016605	PML body	3	78	1.98	0.0017	9606.ENSP00000267163,9606.ENSP00000343741,9606.ENSP00000362441	RB1,ATR,ATRX
COMPARTMENTS	GOCC:0070533	BRCA1-C complex	2	7	2.85	0.0020	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
COMPARTMENTS	GOCC:0000800	Lateral element	2	13	2.58	0.0050	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
COMPARTMENTS	GOCC:0030870	Mre11 complex	2	15	2.52	0.0050	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
COMPARTMENTS	GOCC:0070419	Nonhomologous end joining complex	2	16	2.49	0.0051	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
COMPARTMENTS	GOCC:0000152	Nuclear ubiquitin ligase complex	2	60	1.91	0.0348	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
COMPARTMENTS	GOCC:0000228	Nuclear chromosome	3	320	1.36	0.0348	9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000418960	RB1,BRCA2,BRCA1
COMPARTMENTS	GOCC:0005634	Nucleus	7	4787	0.56	0.0364	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000342924,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,MCPH1,ATR,ATRX,BRCA2,BRCA1
UniProt Keywords	KW-0234	DNA repair	5	325	1.58	4.61e-05	9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	WRN,ATR,ATRX,BRCA2,BRCA1
UniProt Keywords	KW-0238	DNA-binding	6	1971	0.87	0.0053	9606.ENSP00000267163,9606.ENSP00000298139,9606.ENSP00000343741,9606.ENSP00000362441,9606.ENSP00000369497,9606.ENSP00000418960	RB1,WRN,ATR,ATRX,BRCA2,BRCA1
UniProt Keywords	KW-0043	Tumor suppressor	3	177	1.62	0.0061	9606.ENSP00000267163,9606.ENSP00000369497,9606.ENSP00000418960	RB1,BRCA2,BRCA1
UniProt Keywords	KW-0923	Fanconi anemia	2	21	2.37	0.0061	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
UniProt Keywords	KW-0233	DNA recombination	2	77	1.81	0.0490	9606.ENSP00000369497,9606.ENSP00000418960	BRCA2,BRCA1
SMART	SM00292	Breast cancer carboxy-terminal domain	2	22	2.35	0.0325	9606.ENSP00000342924,9606.ENSP00000418960	MCPH1,BRCA1
